The Epidemiology of Plasmodium vivax Among Adults in the Democratic Republic of the Congo: A Nationally-Representative, Cross-Sectional Survey
Authors:
- Nicholas F. BrazeauNBNicholas F. Brazeau
- Cedar L. MitchellCMCedar L. Mitchell
- Andrew P. MorganAMAndrew P. Morgan
- Molly Deutsch-FeldmanMDMolly Deutsch-Feldman
- Oliver John WatsonOWOliver John Watson
- Kyaw L. ThwaiKTKyaw L. Thwai
- Andreea WaltmannAWAndreea Waltmann
- Michael EmchMichael Emch
- Valerie GartnerVGValerie Gartner
- Benjamin RedelingsBRBenjamin Redelings
- Melchior K. MwandagalirwaMMMelchior K. Mwandagalirwa
Preprint
Abstract
Background: Reports of P. vivax infections among Duffy-negative hosts have begun to accumulate throughout sub-Saharan Africa. Despite this growing body of evidence, no nationally representative epidemiological surveys of P. vivax in sub-Saharan Africa nor population genetic analyses to determine the source of these infections have been performed. Methods: To overcome this critical gap in knowledge, we screened nearly 18,000 adults in the Democratic Republic of the Congo (DRC) for P. vivax using samples from the 2013-2014 Demographic Health Survey. Infections were identified by quantitative PCR and confirmed with nested-PCR. P. vivax mitochondrial genomes were constructed after short-read sequencing. Risk factors, spatial distributions and population genetic analyses were explored. Findings: Overall, we found a 2.96% (95% CI: 2.28%, 3.65%) prevalence of P. vivax infections across the DRC. Nearly all infections were among Duffy-negative adults (486/489). Infections were not associated with typical malaria risk-factors and demonstrated small-scale heterogeneity in prevalence across space. Mitochondrial genomes suggested that DRC P. vivax is an older clade that shares its most recent common ancestor with South American isolates. Interpretation: P. vivax is more prevalent across the DRC than previously believed despite widespread Duffy-negativity. Comparison to global and historical P. vivax sequences suggests that historic DRC P. vivax may have been transported to the New World on the wave of European expansion. Our findings suggest congolese P. vivax is an innocuous threat given its relatively flat distribution across space, lack of malaria risk factors, and potentially ancestral lineage. Funding: National Institutes of Health and the Wellcome Trust.Keywords
All Related Versions
- Published version: Nature Communications, 12 (1), 1.
This publication has 31 references indexed in Scilit:
- Spatial and epidemiological drivers of P. falciparum malaria among adults in the Democratic Republic of the CongomedRxiv, 2020
- Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling studyThe Lancet, 2019
- The Impact of Antimalarial Resistance on the Genetic Structure of Plasmodium falciparum in the DRCbioRxiv, 2019
- Growing evidence of Plasmodium vivax across malaria-endemic AfricaPLOS Neglected Tropical Diseases, 2019
- Four human Plasmodium species quantification using droplet digital PCRPLOS ONE, 2017
- Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR CongoScientific Reports, 2013
- The global distribution of the Duffy blood groupNature Communications, 2011
- Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleProceedings of the National Academy of Sciences, 2010
- Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individualsNature Genetics, 1995
- The Resistance Factor toPlasmodium vivaxin BlacksNew England Journal of Medicine, 1976